Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/29/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Gary S. Sachs

Wrong Dr. Gary S. Sachs?

Founder and Director

Bipolar Clinic
 
Background

Employment History

Board Memberships and Affiliations

Education

  • MD
  • MA
  • M.D.
  • medical degree
    University of Maryland School of Medicine
195 Total References
Web References
Depression and Bipolar Support Alliance (DBSA) Advisory Board | CCHR International
www.cchrint.org, 29 Jan 2015 [cached]
The members are: Mark S Bauer, Charles L. Bowden (with financial ties to Abbot, GSK, Janssen), Joseph Calabrese (Abbot, GSK, Janssen), Alan Gelenberg (GSK), Michael E. Thase (GSK, Janssen), Gary S Sachs (lead author of the study who sits on Advisory Board, Speakers Bureau and is consultant for or receives grants from Abbot, GSK, Janssen) and John M. Zajecka (Abbot, GSK).
...
Bauer, along with at least six other DBSA Advisory Board members-Charles L. Bowden (financial ties to Abbot, GSK, Janssen), Joseph Calabrese (Abbot, GSK, Janssen), Alan Gelenberg (GSK), Michael E. Thase (GSK, Janssen), Gary S Sachs (sits on Advisory Board, Speakers Bureau and is consultant for, Grants from Abbot, GSK, Janssen) and John M. Zajecka (Abbot, GSK) -conducted an $26.8 MILLION NIMH-FUNDED clinical study on the so-called Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) coordinated by Massachusetts General Hospital, to examine the course of the "disorder and the effectiveness of current treatments," including at least 7 drugs.[18] Each of those involved in the NIMH-funded study had ties to drug companies (see above) that make the drugs studied.
...
Executive Directors and directors of this includes DBSA members, David Dunner, Alan J. Gelenberg, Mark S. Bauer, Joseph Biederman, Joseph R. Calabrese, Pedro L. Delgado, Barbara Geller, Frederick K. Goodwin Robert M. A. Hirschfeld, Wayne J. Katon, Paul E. Keck Jr., Martin B. Keller, Lauren B. Marangell, Susan L. McElroy, David J. Miklowitz, Charles B. Nemeroff, Charles O'Brien, Robert M. Post, A. John Rush Jr., Gary S. Sachs, Alan F. Schatzberg, Trisha Suppes, Michael E. Thase, Karen D. Wagner, and John M. Zajecka.[215]
...
These included DBSA Scientific Advisory Council members: Robert M.A. Hirschfeld, Joseph R. Calabrese, Paul E. Keck, Robert M. Post, and Gary S. Sachs, as well as Laurie Flynn, then with NAMI (now with TeenScreen); Lydia Lewis, from the then National Depressive and Manic-Depressive Association (now DBSA) and Dr. Robert L. Spitzer, Columbia University and head of DSM-IV review.[267]
...
GARY SACHS, MD, Founder and Director of the Bipolar Clinic and Research Program, Harvard University Boston, MA: Served as a Principal Investigator of the NIHM Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), the largest treatment study ever conducted for "bipolar disorder.
...
These included DBSA Scientific Advisory Council members: Robert M.A. Hirschfeld, Joseph R. Calabrese, Paul E. Keck, Robert M. Post, Gary S. Sachs, as well as Laurie Flynn, then with NAMI (now with TeenScreen); Lydia Lewis, from the then National Depressive and Manic-Depressive Association (now DBSA) and Dr. Robert L. Spitzer, Columbia University and head of DSM-IV review.[345]
Dainippon Sumitomo Pharma Co. Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase III Trials in Bipolar I Depression | 2012 | News Releases | Dainippon Sumitomo Pharma
www.ds-pharma.com, 24 April 2012 [cached]
"Bipolar I depression is highly debilitating for many patients, " said Gary Sachs, M.D., Founding Director of the Bipolar Clinic and Research Program at Massachusetts General Hospital in Boston, Massachusetts in the United States.
DBSA Scientific Advisory Board - Depression and Bipolar Support Alliance
dabsa.convio.net, 31 July 2014 [cached]
Gary Sachs, MD Director, Bipolar Research Program Harvard University
Dr Gary ...
wfsbpindia.com, 6 May 2014 [cached]
Dr Gary Sachs
...
Dr Sachs is a Associate Professor in Psychiatry at Harvard Medical School; Clinical Assistant in Psychiatry and Director, Bipolar Mood Disorder Program . r Sachs earned his medical degree at the University of Maryland School of Medicine. He interned in family practice and psychiatry at University of Maryland Hospital in Baltimore and was a resident in psychiatry and Chief Resident, Acute Psychiatry Service, at Massachusetts General Hospital in Boston. He is the Principal Investigator of the NIMH Systematic Treatment Enhancement Program for Bipolar disorder. His areas of academic interest include psychopharmacology, bipolar mood disorder, and development of practice guidelines for the treatment of bipolar mood disorder. He serves on the scientific advisory board of the National Depression and Manic Depression Association and is Co-editor-in-chief of Clinical Approaches to Bipolar Disorder and on numerous editorial boards. Dr Sachs has authored over 150 articles, abstracts, books, reviews, and book chapters.
CME Activity Details - Applying Performance Measures Through a Chronic Disease Model to Optimize Treatment of Bipolar Mania
www.cmeoutfitters.com, 19 June 2011 [cached]
Gary S. Sachs, MD
...
Gary S. Sachs, MD Co-Director, Bipolar Clinic and Research Program Massachusetts General Hospital
...
Dr. Sachs has disclosed that he receives grant support from GlaxoSmithKline, National Institute of Mental Health, and Repligen Corporation. He serves as a consultant to, or on the advisory boards of, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Cephalon, Inc., Concordant Rater Systems, Eli Lilly and Company, GlaxoSmithKline, Janssen, L.P., Merck & Co., Inc., Otsuka America Pharmaceutical, Inc., Pfizer Inc., Schering-Plough Corporation, Sepracor Inc., Repligen Corporation, Sanofi-aventis, and Wyeth Pharmaceuticals.
Other People with the name "Sachs":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304